Vikas Lifecare delivered a remarkable financial turnaround in the March 2026 quarter, posting a consolidated net profit of ₹41.57 crore compared to a net loss of ₹2.90 crore in the corresponding quarter of the previous year. According to the company's latest earnings results for Q4 FY2026, this represents a complete reversal of fortunes for the company during the quarter ended March 31, 2026. The company's basic earnings per share from continuing operations was ₹0.22 compared to a basic loss per share of ₹0.02 in the same quarter last year.
The company's sales revenue increased by 24.72% to ₹168.62 crore in Q4 FY2026, up from ₹135.20 crore in the same quarter of the previous year. As reported by the company's latest financial results, revenue for the quarter was ₹169.50 crore compared to ₹156.29 crore a year ago. This significant revenue growth contributed to the company's improved profitability during the quarter, demonstrating strong operational performance and effective business strategies.
For the full financial year 2026, Vikas Lifecare achieved a net profit of ₹18.41 crore compared to a net loss of ₹10.61 crore in the previous year. According to the company's annual results, sales for the full year rose 4.03% to ₹499.36 crore from ₹480.02 crore in FY2025. Revenue for the full year was ₹635.10 crore compared to ₹505.99 crore in the previous year, showing consistent growth momentum throughout the year and demonstrating the company's ability to maintain operational efficiency across different quarters.
The company's diluted earnings per share from continuing operations was ₹0.22 compared to a diluted loss per share of ₹0.02 in the corresponding quarter last year. For the full year, basic earnings per share from continuing operations was ₹0.1 compared to a basic loss per share of ₹0.06 in FY2025. This significant improvement in earnings per share demonstrates the company's enhanced profitability and operational efficiency during both the quarter and full year periods, reflecting improved business fundamentals and strategic execution.
